Brain imaging with FDDNP proved to be more effective than other imaging methods for identifying patients with the disease.
相对于其他的成像方法，应用FDDNP的大脑成像能够更加高效的鉴定病人。
Follow-up of the volunteers, conducted two years after initial testing, showed that FDDNP scans continued to correlate well with clinical symptoms.
最初的试验之后，志愿者的追踪调查持续了2年，显示FDDNP扫描结果与临床症状一直密切相关。
FDDNP PET scan was able to differentiate patients with Alzheimer's from those with mild mental impairment or no impairment better than the FDG PET scan or MRI scan.
相对于FDGPET扫描或MRI扫描，FDDNP PET扫描能够更好的区分AD病人和那些轻度认知损伤或无认知损伤的人。
In brain imaging studies, the compound, known as FDDNP, bound to the plaques and tangles within the brain that are the characteristic features of Alzheimer's disease.
在大脑成像研究中，这种被称为FDDNP的化合物与作为脑中ad病理特征的色斑和缠结相连。
When compared with PET scanning using the standard molecule FDG, the FDDNP scanning technique was found to be more accurate for detecting differences among the study participants.
当与应用标准分子FDG的PET扫描比较时，FDDNP扫描技术被认为能够更加精确的检测研究参与者的差异。
When compared with PET scanning using the standard molecule FDG, the FDDNP scanning technique was found to be more accurate for detecting differences among the study participants.
当与应用标准分子FDG的PET扫描比较时，FDDNP扫描技术被认为能够更加精确的检测研究参与者的差异。
应用推荐